Flagship V VentureLabs Rx Fund, L.P.

CIK 1724939 · last filed 2023-06-08

Flagship V VentureLabs Rx Fund, L.P. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $10.1M of SANA on Jun 8, 2023. Across all open-market trades the lifetime net is +$109.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $34.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$34.49M

Companies

2

Total Filings

4

Lifetime Open-Market Net

$109.87M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
SANA	10%+ Owner	10,743,293	$3.21	$34.49M	-$10.13M	1	2023-06-08
Omega Therapeutics, Inc. (OMGA) Delisted	10%+ Owner	5,514,707	$0.14	$786.4K	$120.00M	1	2021-08-05

Recent Filings

4 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-06-08	SANA	Sell (S)	−1,615,032	-$10.13M	EDGAR
2023-06-07	SANA	Notice (144)	−39,830	-$254.5K	EDGAR
2023-05-24	SANA	Notice (144)	−85,334	-$598.2K	EDGAR
2021-08-05	Omega Therapeutics, Inc. (OMGA) Delisted	Mixed	+142,231,260	$120.00M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.